Page last updated: 2024-10-25

cisapride and Elevated ICP (Intracranial Pressure)

cisapride has been researched along with Elevated ICP (Intracranial Pressure) in 1 studies

Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.

Research Excerpts

ExcerptRelevanceReference
"Cisapride was ineffective at 1 mg/kg but caused a partial reversal at the 5- and 10-mg/kg doses (46."1.30Acute intracranial hypertension-induced inhibition of gastric emptying: evaluation in conscious rats. ( Gupta, YK; Kacker, V; Mehta, VS, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kacker, V1
Mehta, VS1
Gupta, YK1

Other Studies

1 other study available for cisapride and Elevated ICP (Intracranial Pressure)

ArticleYear
Acute intracranial hypertension-induced inhibition of gastric emptying: evaluation in conscious rats.
    European journal of pharmacology, 1999, Mar-12, Volume: 369, Issue:1

    Topics: Acute Disease; Analgesics, Non-Narcotic; Animals; Antihypertensive Agents; Antipsychotic Agents; Bre

1999